Form 8-K - Current report:
SEC Accession No. 0001104659-20-105660
Filing Date
2020-09-16
Accepted
2020-09-16 16:05:17
Documents
14
Period of Report
2020-09-16
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2030985-1_8k.htm   iXBRL 8-K 30427
2 EXHIBIT 99.1 tm2030985d1_ex99-1.htm EX-99.1 12716
3 GRAPHIC tm2030985d1_ex99-1img001.jpg GRAPHIC 15416
  Complete submission text file 0001104659-20-105660.txt   241964

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA vcel-20200916.xsd EX-101.SCH 3174
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vcel-20200916_lab.xml EX-101.LAB 34591
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vcel-20200916_pre.xml EX-101.PRE 22702
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2030985-1_8k_htm.xml XML 3473
Mailing Address 64 SIDNEY ST. CAMBRIDGE MA 02139
Business Address 64 SIDNEY ST. CAMBRIDGE MA 02139 7349305555
Vericel Corp (Filer) CIK: 0000887359 (see all company filings)

EIN.: 943096597 | State of Incorp.: MI | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35280 | Film No.: 201178898
SIC: 2836 Biological Products, (No Diagnostic Substances)